mendo
New member
OK...I've seen a ton of Tbol threads lately...but there is something I haven't seen mentioned. WATER INTAKE. I'm not sure if the other Tbol guys on here have experinced this, but Tbol really puts a strain on your kidneys. I have mentioned in a few threads that I had zero sides on Tbol...well that was while drinking around 2 gallons of water each day! If your water intake is not high you may get lower back pain. It happened to me a few times toward the end of my last Tbol cycle, and I just thought it was back pumps like Dbol (thats what it felt like to me). But after some research I noticed that it only happened when my water intake wasn't high.
This is because the metabolites from Tbol are mainly removed by the kidneys...not the liver. I've seen this posted a few times, and they mention it...
[The pharmacokinetics of Oral-Turinabol in humans]
[Article in German]
Schumann W.
Institut fur Mikrobiologie und experimentelle Therapie (ZIMET), Jena.
Disposition and excretion of the anabolic steroid Oral-Turinabol (1;4-chloro-17 alpha-methyl-androsta-1,4-diene-17 beta-hydroxy-3-one) were investigated in male volunteers. Following single p.o. and i.v. administration of the tritium-labelled compound the plasma concentration courses of total radioactivity (1 and 1-metabolites) and of the unchanged parent drug as well as the urinary excretion were estimated. From these data model independent pharmacokinetic parameters based on statistical moments were calculated. 1 is almost completely absorbed after p.o. administration of 10 mg per volunteer. Peak concentrations of total radioactivity and of 1 in plasma were reached about 3 h p.a. Irregularities observed in the plasma level profile following both p.o. and i.v. administration of 1 are due to a marked enterohepatic circulation. Orally given 1 is subject to a first-pass effect, resulting in a diminished systematic availability. The AUC-ratio of the unchanged drug and the total radioactivity of 1 : 13 shows the predominance of metabolites in plasma. After i.v. administration the disposition of unchanged 1 was found biphasically with a terminal half-life of 16 h. 1 and its metabolites are preferentially excreted via the kidneys. The urinary total radioactivity represented about 60% of the dose following both administrations. Due to its affinity to SHBG 1 is able to compete for the protein binding of testosterone, resulting in an increased plasma level of non protein-bound testosterone.
Also, it is a 17aa oral...so the liver still takes a hit as well.
This is because the metabolites from Tbol are mainly removed by the kidneys...not the liver. I've seen this posted a few times, and they mention it...
[The pharmacokinetics of Oral-Turinabol in humans]
[Article in German]
Schumann W.
Institut fur Mikrobiologie und experimentelle Therapie (ZIMET), Jena.
Disposition and excretion of the anabolic steroid Oral-Turinabol (1;4-chloro-17 alpha-methyl-androsta-1,4-diene-17 beta-hydroxy-3-one) were investigated in male volunteers. Following single p.o. and i.v. administration of the tritium-labelled compound the plasma concentration courses of total radioactivity (1 and 1-metabolites) and of the unchanged parent drug as well as the urinary excretion were estimated. From these data model independent pharmacokinetic parameters based on statistical moments were calculated. 1 is almost completely absorbed after p.o. administration of 10 mg per volunteer. Peak concentrations of total radioactivity and of 1 in plasma were reached about 3 h p.a. Irregularities observed in the plasma level profile following both p.o. and i.v. administration of 1 are due to a marked enterohepatic circulation. Orally given 1 is subject to a first-pass effect, resulting in a diminished systematic availability. The AUC-ratio of the unchanged drug and the total radioactivity of 1 : 13 shows the predominance of metabolites in plasma. After i.v. administration the disposition of unchanged 1 was found biphasically with a terminal half-life of 16 h. 1 and its metabolites are preferentially excreted via the kidneys. The urinary total radioactivity represented about 60% of the dose following both administrations. Due to its affinity to SHBG 1 is able to compete for the protein binding of testosterone, resulting in an increased plasma level of non protein-bound testosterone.
Also, it is a 17aa oral...so the liver still takes a hit as well.

Please Scroll Down to See Forums Below 









